A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...